Free
Case Reports  |   November 2002
Visual Loss after Use of Nitrous Oxide Gas with General Anesthetic in Patients with Intraocular Gas Still Persistent Up to 30 days after Vitrectomy
Author Affiliations & Notes
  • Brendan J. Vote, M.D.
    *
  • Richard H. Hart, M.D.
  • David R. Worsley, M.D.
  • James H. Borthwick, M.D.
    §
  • Stephen Laurent, M.D.
  • Archibald J. McGeorge, M.D.
    #
  • *Vitreoretinal Fellow, †Senior Registrar, ∥Consultant Anaesthetist, Department of Anaesthesia. #Vitreoretinal Surgeon, Auckland Hospital, Auckland. ‡Vitreoretinal Surgeon, Waikato Hospital, Hamilton. §Vitreoretinal Surgeon, Christchurch Hospital, Christchurch.
  • Received from the Department of Ophthalmology, Department of Anaesthesia, Auckland Hospital, Auckland. Department of Ophthalmology, Waikato Hospital, Hamilton. Department of Ophthalmology, Christchurch Hospital, Christ- church; Department of Anaesthesia, Auckland Hospital, Auckland, New Zealand.
Article Information
Case Reports
Case Reports   |   November 2002
Visual Loss after Use of Nitrous Oxide Gas with General Anesthetic in Patients with Intraocular Gas Still Persistent Up to 30 days after Vitrectomy
Anesthesiology 11 2002, Vol.97, 1305-1308. doi:
Anesthesiology 11 2002, Vol.97, 1305-1308. doi:
INTRAOCULAR gas may enter an eye in a variety of ways: penetrating injury, infection, rapid decompression, gas bubble disease, or from therapeutic interventions by ophthalmologists. 1 Therapeutic use of intraocular gas provides internal retinal tamponade for retinal breaks or detachment, macular hole repair, and complicated diabetic vitrectomy. Unfortunately, gases used in intraocular surgery introduce a variety of potential problems. One problem is posed for patients requiring subsequent surgery (not necessarily ophthalmic) in the postoperative period while intraocular gas may still be present in the eye. We report three cases from three different centers where adverse events occurred after nitrous oxide (N2O)-induced general anesthesia in patients following recent vitrectomy with use of intraocular gas. A summary of principles of intraocular gases is provided, including recommendations for prevention and management of N2O-induced anesthesia-related intraocular gas complications.
Case Reports
Case 1
A 73-yr-old man underwent vitrectomy and internal drainage of a large subretinal hemorrhage at the right macula (table 1for summary of patient data). After fluid-air exchange, the eye (vitreous cavity) was filled with 14% perfluoropropane (C3F8) gas. Twenty-two days postoperatively, the patient underwent elective total hip replacement surgery during general anesthesia, which included N2O. The patient awoke from surgery with no perception of light (NPL) vision in the eye with intraocular gas. No visual recovery occurred and optic atrophy developed in the right eye.
Table 1. Pertinent Preoperative, Operative, and Postoperative Data from Each Case
Image not available
Table 1. Pertinent Preoperative, Operative, and Postoperative Data from Each Case
×
Case 2
An 80-yr-old man underwent vitrectomy for retinal detachment during general anesthesia. The eye was filled with 20% C3F8gas at the end of the procedure. The following day, examination showed a flat retina, normal intraocular pressure (IOP), and 70% gas fill (percentage vitreous cavity volume). Unfortunately urinary retention developed in the patient following the operation, requiring catheterization. Nine days postoperatively, the patient was progressing well, with hand movement visual acuity, 60% gas fill, and a flat inferior retina. He remained catheterized and transurethral prostate resection was performed during general anesthesia. N2O was used for the complete procedure. Overnight, the patient experienced ocular pain, but no emergent ophthalmic review was sought. When the ophthalmologist asked to see the patient the next day, the patient's IOP was slightly increased at 23 mmHg, and clinical features of total central retinal artery occlusion were present (marked relative afferent pupil defect, cherry red spot). Despite systemic and topical IOP-lowering agents, the patient's vision had deteriorated to NPL, which never recovered. Subsequent review confirmed development of optic atrophy.
Case 3
A 75-yr-old man underwent vitrectomy for macula hole and the eye filled with 20% C3F8gas. He then underwent emergency orthopedic surgery for a fractured neck of femur repair, with N2O use in general anesthesia 1 month later. Immediately after the orthopedic procedure, he reported loss of vision in his left eye to the staff in the recovery room. Examination 90 min after surgery revealed light perception visual acuity, a relative afferent pupil defect, and 50–60% gas bubble in the vitreous cavity. Fortunately visual acuity recovered to 6/24, though optic nerve pallor developed.
Background
Intraocular Gas-Intraocular Pressure Relation
Whenever intraocular gas is used, the surgeon risks producing increased IOP from excessive volume and/or expansion of the intraocular gas. Gas expansion may cause ocular hypertension (increased IOP) in four circumstances: decreasing barometric pressure (altitude), influx of N2O, excessive concentration of an expanding gas, decreased facility of outflow (aqueous drainage) through the trabecular meshwork. 1 
As the eye is somewhat elastic and contains fluid and solids, the relation between ocular volume and gas pressure is more complex than is predicted by ideal gas laws (Boyle's, Charles’, Avagadro's and Dalton's laws). Nonetheless these laws allow an understanding of the behavior of intraocular gases in the clinical setting. Of perhaps greater relevance, Fick's law determines growth or shrinkage of gas bubbles in the eye. 1 Essentially, behavior of an intraocular gas bubble after introduction into the globe depends on its solubility compared with atmospheric gases (room air). Thus, three types of gases may be introduced: room air; a gas that is less soluble or less diffusible than room air (e.g.  , sulfurhexaflouride [SF6] and C3F8), which thus persists longer than air; a gas that is more soluble or diffusible than room air (e.g.  , carbon dioxide and N2O) and thus disappears more quickly than air. 1 
Specific Gases Pertinent to the Ophthalmic- Anesthetic Situation
A variety of gases can be used in an ophthalmic setting. Filtered room air, SF6, and C3F8are those most commonly used. The duration of intraocular gas varies with the volume, concentration, and type of gas used. Larger more concentrated volumes of gases less soluble than air last longer. 2 Air typically resorbs within a few days. SF6lasts 7–10 days; C3F8, 4–6 weeks; though C3F8durations of more than 70 days have been reported. 3 C3F8, with its longer duration in the eye, has been shown to be superior to SF6in the management of complicated retinal detachments in which longer tamponade periods are required. 4 Silicone oil is an alternate intraocular tamponade agent that avoids intraocular gas-related problems, while providing long-term tamponade protection. However, it introduces its own complications, requires an additional removal procedure, and does not provide tamponade protection sufficiently for its use in conditions such as macular hole. 4,5 
Unlike air, SF6and C3F8are expansile gases. During the expansion phase, nitrogen and other blood gases enter the bubble more rapidly than SF6or C3F8disappears, which leads to exponential expansion of the bubble. SF6and C3F8gases can be mixed with air and used in a nonexpansile (isovolumetric) concentrations or used in an expansile fashion depending on surgical factors and desired effects. One hundred percent SF6expands to twice the injected volume over 24 h, while 100% C3F8expands to four times the injected volume over 3–7 days. The expansion phase of SF6and C3F8gases is such that IOP is able to normalize faster than the rate of expansion of the gas and, by allowing smaller injection volumes, avoids potential problems of injecting larger volumes of nonexpansile gas (e.g.  , air) into a closed eye. 1 
Effect of Intraocular Gas Injection on Intraocular Pressure
Injection of 0.3 ml gas (∼5% vitreal volume) is enough to increase the IOP to greater than 70 mmHg and close the central retinal artery; though usually IOP decreases to normal pressures within 15 min. 6 Injection of larger volumes or expansile mixes can reach a much higher IOP and take longer before normalization of IOP. 16 There is no precise duration of increased IOP greater than central retinal artery perfusion pressure that will lead to permanent visual loss; however, primate models suggest irreversible damage occurs if retinal artery obstruction is present for approximately 90 min. 7 Clinically, increased IOP is known to close the central retinal artery and this can be visualized during the period of increased IOP. On resolution to normal IOP, however, fundal appearance can vary from normal reperfused vessels to the classic cherry red spot, which may take some hours to develop. 8,9 Ultimately, however, an eye damaged by central retinal artery occlusion (CRAO) will typically show evidence of optic disc pallor, attenuated vessels, and nerve fiber layer loss in the months that follow. 8 
Influence of Nitrous Oxide on Intraocular Gas Behavior
Nitrous oxide is much more soluble than other gases and therefore exerts a potent effect on all intraocular gases. If N2O is used when gas is present in a closed eye (e.g.  , after injection or in the postoperative period), then the volume of intraocular gas increases while N2O is being used and only stops expanding once N2O is discontinued. A more than threefold volume increase may be seen over 1 h of N2O use, 10 which is easily sufficient to close the central retinal artery.
Discussion
Despite numerous studies of the effect of N2O on bubble volume, secondary glaucoma is not commonly reported, though most anesthesiologists recognize that N2O is contraindicated if intraocular gas is present or planned to be used in a closed eye. 10–15 Although IOP problems and CRAO are well-recognized complications of intraocular gas use, 6 16–19 our case series represents the first reported cases of permanent visual loss through the postoperative use of N2O-induced general anesthesia in eyes with intraocular gas. Although not excluded in these cases, embolic phenomena (e.g.  , fat emboli) typically occur as a shower and would likely have additional embolic findings, both in the affected eye and elsewhere. 8 Similarly, other anesthetic factors have been implicated in visual loss, especially hemodynamic, such as hypotension, patient posturing, medications, and blood loss. 20–22 These diseases typically would cause anterior or posterior ischemic optic neuropathy rather than CRAO. 21 Aside from patient 2, who had intraoperative hypotension, no other factors implicated in visual loss were evident in these cases. Case 2 clearly showed CRAO as the mechanism of visual loss, making the hypotension, though possibly contributory, perhaps less significant than the gas-related mechanism. Although only case 2 showed clear evidence of CRAO, increased IOP in itself is not known to cause anterior or posterior ischemic optic neuropathy. However, anterior or posterior ischemic optic neuropathy can ultimately lead to disc pallor, and thus could not be excluded as causes in cases 1 and 3. 23 
It is important for anesthesiologists to be aware that an intraocular gas bubble can persist in the eye for up to 10 weeks after ocular surgery. Use of highly soluble gases, such as N2O, in the presence of intraocular gas can lead to significant visual complications. In the current patients, complications developed associated with N2O use 22, 9, and 30 days after eye surgery. This is because N2O rapidly enters the gas bubble, inducing an increase in gas volume inside the essentially rigid, closed eye. The rapid and extreme increase in pressure closes the central retinal artery, leading to the observed visual loss. Because the patient is anesthetized at the time this damage is presumably occurring, they do not report pain (as might normally be expected in an awake patient with extreme elevation of IOP). Presumably, IOP rapidly returns to asymptomatic values soon after anesthetic completion, as suggested experimentally. 11 
Methods to Reduce Risk of Nitrous Oxide Visual Loss
Prevention.
In the ophthalmic setting, communication between surgeon and anesthesiologist usually avoids gas-related complications, though, occasionally, inadvertent N2O problems have been detected intraoperatively. 1 Clearly, surgeons have a responsibility to increase patient awareness regarding the risks of further surgery when intraocular gas has been used and to ensure adequate communication between surgeon and anesthesiologist preoperatively. In addition, we propose the use of a simple warning bracelet, for patients to wear in the postoperative period until the gas bubble has dissolved (fig. 1). The importance of such bracelets is even more relevant in the emergency situation when patients may be incapacitated and unable to relay intraocular gas history.
Fig. 1. Nitrous oxide warning bracelet placed at the time of intraocular gas injection and removed only after the gas has resorbed.
Fig. 1. Nitrous oxide warning bracelet placed at the time of intraocular gas injection and removed only after the gas has resorbed.
Fig. 1. Nitrous oxide warning bracelet placed at the time of intraocular gas injection and removed only after the gas has resorbed.
×
Management of Acute Episode if Detected
If a problem is recognized intraoperatively, then immediate steps should be taken. N2O should be ceased immediately; ventilation, commenced with 100% oxygen. One hundred percent oxygen has been shown to lead to faster reversal of bubble expansion than room air alone. 24 In addition, adequate systemic perfusion should be ensured. Urgent consultation with an ophthalmologist should be obtained, with ongoing emergency management guided by the ophthalmologist. If ophthalmology consultation is not available and if after 5 min the eye continues to feel hard during palpation (using other eye for comparison), then consideration of pars plana paracentesis should be given to vent excess gas from the eye. Using a short (1/2 in) needle (26–30 gauge), pierce the 1-mm thick sclera of the eye 3.5–4 mm from the limbus (junction between clear cornea and white sclera). The needle should be directed perpendicularly toward the center of the eye. A few seconds is typically enough to reduce IOP to safe pressures (removal of a precise amount is not essential).
The authors thank Jillian Blakley, R.N., Operating Theatre, Mercy Hospital, Auckland, New Zealand.
References
Whitacre M: Principles and Applications of Intraocular Gas, 1st edition. Edited by Blodi BA, Gottlieb JL. Boston, Butterworth-Heinemann, 1998, pp 3–88
Chang S, Lincoff HA, Coleman DJ, Fuchs W, Farber ME: Perfluorocarbon gases in vitreous surgery. Ophthalmology 1985; 92: 651–6Chang, S Lincoff, HA Coleman, DJ Fuchs, W Farber, ME
Lincoff H, Coleman J, Kreissig I, Richard G, Chang S, Wilcox LM: The perfluorocarbon gases in the treatment of retinal detachment. Ophthalmology 1983; 90: 546–51Lincoff, H Coleman, J Kreissig, I Richard, G Chang, S Wilcox, LM
Abrams GW, Azen SP, McCuen BW, 2nd, Flynn HW, Jr, Lai MY, Ryan SJ: Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: Results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol 1997; 115: 335–44Abrams, GW Azen, SP McCuen, BW Flynn, HW Lai, MY Ryan, SJ
Han L, Cairns JD, Campbell WG, McCombe MF, Heriot WJ, Heinze JB: Use of silicone oil in the treatment of complicated retinal detachment: Results from 1981 to 1994. Aust N Z J Ophthalmol 1998; 26: 299–304Han, L Cairns, JD Campbell, WG McCombe, MF Heriot, WJ Heinze, JB
Abe T, Nakajima A, Nakamura H, Ishikawa M, Sakuragi S: Intraocular pressure during pneumatic retinopexy. Ophthalmic Surg Lasers 1998; 29: 391–6Abe, T Nakajima, A Nakamura, H Ishikawa, M Sakuragi, S
Hayreh SS, Kolder HE: Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980; 87: 75–8Hayreh, SS Kolder, HE
Brown G. Retinal Arterial Obstruction: Focal Points 1994; XII: 1–11
Malinowski SM, Pesin SR: Visual field loss caused by retinal vascular occlusion after vitrectomy surgery. Am J Ophthalmol 1997; 123: 707–8Malinowski, SM Pesin, SR
Stinson TW III, Donlan JV Jr: Interaction of intraocular air and sulfur hexafluoride with nitrous oxide: A computer simulation. A nesthesiology 1982; 56: 385–8Stinson, TW Donlan, JV
Smith RB, Carl B, Linn JG, Nemoto E: Effect of nitrous oxide on air in vitreous. Am J Ophthalmol 1974; 78: 314–7Smith, RB Carl, B Linn, JG Nemoto, E
Briggs M, Wong D, Groenewald C, McGalliard J, Kelly J, Harper J: The effect of anaesthesia on the intraocular volume of the C3F8 gas bubble: I. Eye 1997; 11: 47–52Briggs, M Wong, D Groenewald, C McGalliard, J Kelly, J Harper, J
Mostafa S, Wong S, Snowdon S, Ansons A, Kelly J, McGalliard J: Nitrous oxide and internal tamponade during vitrectomy. Br J Ophthalmol 1991; 75: 726–8Mostafa, S Wong, S Snowdon, S Ansons, A Kelly, J McGalliard, J
Wolf GL, Capuano C, Hartung J: Effect of nitrous oxide on gas bubble volume in the anterior chamber. Arch Ophthalmol 1985; 103: 418–9Wolf, GL Capuano, C Hartung, J
Wolf GL, Capuano C, Hartung J: Effect of nitrous oxide on gas bubble volume (letter). Arch Ophthalmol 1985; 103: 1274Wolf, GL Capuano, C Hartung, J
Chen PP, Thompson JT: Risk factors for elevated intraocular pressure after the use of intraocular gases in vitreoretinal surgery. Ophthalmic Surg Lasers 1997; 28: 37–42Chen, PP Thompson, JT
Sabates WI, Abrams GW, Swanson DE, Norton EW: The use of intraocular gases. The results of sulfur hexafluoride gas in retinal detachment surgery. Ophthalmology 1981; 88: 447–54Sabates, WI Abrams, GW Swanson, DE Norton, EW
Sabates NR, Tolentino FI, Arroyo M, Freeman HM: The complications of perfluoropropane gas use in complex retinal detachments. Retina 1996; 16: 7–12Sabates, NR Tolentino, FI Arroyo, M Freeman, HM
Abrams GW, Sabates WI, Goldman I: The results of sulphur hexafluoride gas in vitreous surgery. Am J Ophthalmol 1982; 94: 165–71Abrams, GW Sabates, WI Goldman, I
Remigio D, Wertenbaker C: Post-operative bilateral vision loss. Surv Ophthalmol 2000; 44: 426–32Remigio, D Wertenbaker, C
Williams EL, Hart WM Jr, Tempelhoff R: Postoperative ischemic optic neuropathy. Anesth Analg 1995; 80: 1018–29Williams, EL Hart, WM Tempelhoff, R
Jampol LM, Goldbaum M, Rosenberg M, Bahr R: Ischemia of ciliary arterial circulation from ocular compression. Arch Ophthalmol 1975; 93: 1311–7Jampol, LM Goldbaum, M Rosenberg, M Bahr, R
Hayreh SS: Posterior ischaemic optic neuropathy. Ophthalmologica 1981; 182: 29–41Hayreh, SS
Hyldegaard O, Madsen J: Effect of air, heliox, and oxygen breathing on air bubbles in aqueous tissues in the rat. Undersea Hyperb Med 1994; 21: 413–24Hyldegaard, O Madsen, J
Fig. 1. Nitrous oxide warning bracelet placed at the time of intraocular gas injection and removed only after the gas has resorbed.
Fig. 1. Nitrous oxide warning bracelet placed at the time of intraocular gas injection and removed only after the gas has resorbed.
Fig. 1. Nitrous oxide warning bracelet placed at the time of intraocular gas injection and removed only after the gas has resorbed.
×
Table 1. Pertinent Preoperative, Operative, and Postoperative Data from Each Case
Image not available
Table 1. Pertinent Preoperative, Operative, and Postoperative Data from Each Case
×